World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
54176
World Ranking
6928
National Ranking
81

Overview

André Scheen is affiliated with the University of Liège in Belgium, with a primary focus on medicine. Their research spans over 241 publications in the medical field, with a specialization in endocrinology, diabetes, and metabolism. The subfields covered in their work also include molecular biology, pharmacology, surgery, and physiology.

The scientist's research topics address key aspects of diabetes and metabolism. These include:

  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Pharmacology and Obesity Treatment
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diet and metabolism studies
  • Potassium and Related Disorders

André Scheen has contributed publications extensively in a number of venues frequently associated with diabetes and metabolic diseases. The main publication venues include:

  • Diabetes & Metabolism
  • Médecine des Maladies Métaboliques
  • Revue Médicale Suisse
  • Diabetes Epidemiology and Management
  • The Lancet Diabetes & Endocrinology

The researcher has collaborated with several frequent coauthors during their career. Notable colleagues include:

  • Pierre Delanaye
  • Michel Marre
  • Jean-François Gautier
  • Pierre Gourdy
  • Rudolf Prager

Recent publications by André Scheen document work on various aspects of diabetes treatment and complications. Selected papers include:

  • "Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus," 2020, Nature Reviews Endocrinology
  • "Metformin and COVID-19: From cellular mechanisms to reduced mortality," 2020, Diabetes & Metabolism
  • "Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports," 2020, Diabetes & Metabolism

Other notable papers associated with the field but authored by different researchers include studies on chronic kidney disease and cardiovascular outcomes, reflecting interconnected research interests within diabetic comorbidities.

Best Publications

  • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

    John A. Dormandy;Bernard Charbonnel;David J A Eckland;Erland Erdmann

  • ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

    Lars Ryden;Peter J. Grant;Stefan D. Anker;Christian Berne

  • Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

    Nathalie Esser;Sylvie Legrand-Poels;Jacques Piette;André J. Scheen

  • Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

    Luc F Van Gaal;Aila M Rissanen;André J Scheen;Olivier Ziegler

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

    André J Scheen;Nick Finer;Priscilla Hollander;Michael D Jensen

  • Effect of valsartan on the incidence of diabetes and cardiovascular events.

    John McMurray;R Holman;Steven Haffner;M Bethel

  • Clinical pharmacokinetics of metformin.

    André J. Scheen

  • RECOMMANDATIONS 2012 EN DIABÉTOLOGIE: Prise en charge de l'hyperglycémie dans le diabète de type 2: une approche centrée sur le patient

    André Scheen;Chantal Mathieu

  • Roles of circadian rhythmicity and sleep in human glucose regulation

    E. Van Cauter;K. S. Polonsky;André Scheen

  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Carel W le Roux;Carel W le Roux;Arne Astrup;Ken Fujioka;Frank Greenway

  • Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.

    Françoise Luyckx;Claude Desaive;Albert Thiry;W. Dewe

  • Effect of nateglinide on the incidence of diabetes and cardiovascular events

    Rury R. Holman;Steven M. Haffner;Steven M. Haffner;John J. McMurray;M. Angelyn Bethel;M. Angelyn Bethel

  • Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.

    André J. Scheen

  • Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

    Marc A. De Hert;Ruud van Winkel;Dominique Van Eyck;Linda Hanssens

  • Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

    Françoise Luyckx;Pierre Lefebvre;André Scheen

  • Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system

    André J Scheen

  • Magnesium and glucose homeostasis

    G. Paolisso;André Scheen;F. D'Onofrio;Pierre Lefebvre

  • Renin-angiotensin system inhibition prevents type 2 diabetes mellitus - part 1: a meta-analysis of randomised clinical trials

    André Scheen

  • Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.

    André Scheen

Frequent Co-Authors

Marc De Hert
Marc De Hert KU Leuven
Luc Van Gaal
Luc Van Gaal University of Antwerp
Patrizio Lancellotti
Patrizio Lancellotti University of Liège
Giuseppe Paolisso
Giuseppe Paolisso University of Campania "Luigi Vanvitelli"
Jean-Pierre Després
Jean-Pierre Després Université Laval
Jacques Piette
Jacques Piette University of Liège
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
Ole Schmitz
Ole Schmitz Aarhus University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options related to medicine doesn't have to be limited to traditional MD programs. Today, there are several flexible online degrees that let you advance your medical career or enter the healthcare field from different pathways.

For nurses seeking the highest level of practice, the cheapest BSN to DNP programs offer an affordable and convenient route to a Doctor of Nursing Practice degree. Likewise, pharmacy professionals can consider the best online pharmacy school programs to gain advanced qualifications with flexible study options.

If you’re interested in the growing field of digital health records and analytics, accredited healthcare informatics degree programs can help you enter or advance in health information management roles. For those interested in medical administration, you can quickly start a career from home with billing and coding classes online.

These online pathways can be stepping stones to lucrative healthcare careers—some even without the need for previous clinical experience or medical school. They allow you to specialize, upskill, or transition into healthcare with more flexibility than ever before.

Best Scientists Citing André Scheen

Trending Scientists

Recently Published Articles